GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,208,000 | +21.4% | 5,570 | -35.4% | 0.00% | 0.0% |
| Q4 2020 | $995,000 | -54.8% | 8,625 | -61.8% | 0.00% | -66.7% |
| Q3 2020 | $2,199,000 | +18.1% | 22,591 | +48.9% | 0.00% | +50.0% |
| Q2 2020 | $1,862,000 | +39.1% | 15,176 | -0.8% | 0.00% | 0.0% |
| Q1 2020 | $1,339,000 | -15.1% | 15,296 | +1.4% | 0.00% | 0.0% |
| Q4 2019 | $1,578,000 | -9.1% | 15,091 | -0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,736,000 | -41.8% | 15,092 | -12.8% | 0.00% | -50.0% |
| Q2 2019 | $2,983,000 | -3.0% | 17,301 | -5.2% | 0.00% | -20.0% |
| Q1 2019 | $3,076,000 | +42.1% | 18,249 | -17.9% | 0.01% | +25.0% |
| Q4 2018 | $2,164,000 | -51.2% | 22,217 | -13.5% | 0.00% | -42.9% |
| Q3 2018 | $4,438,000 | +52.2% | 25,691 | +22.9% | 0.01% | +40.0% |
| Q2 2018 | $2,916,000 | +120.1% | 20,900 | +77.8% | 0.01% | +150.0% |
| Q1 2018 | $1,325,000 | +18.6% | 11,757 | +38.9% | 0.00% | 0.0% |
| Q4 2017 | $1,117,000 | +42.1% | 8,464 | +9.3% | 0.00% | 0.0% |
| Q3 2017 | $786,000 | +12.3% | 7,746 | +10.9% | 0.00% | 0.0% |
| Q2 2017 | $700,000 | +3.2% | 6,983 | +24.5% | 0.00% | 0.0% |
| Q1 2017 | $678,000 | +55.5% | 5,609 | +43.9% | 0.00% | +100.0% |
| Q4 2016 | $436,000 | +7.7% | 3,898 | +27.7% | 0.00% | 0.0% |
| Q3 2016 | $405,000 | – | 3,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|